Trader’s Watch List: Epizyme (NASDAQ:EPZM), Yandex N.V. (NASDAQ:YNDX), Citigroup Inc. (NYSE:C), Portola Pharmaceuticals (NASDAQ:PTLA), Frontline (NYSE:FRO)

On Monday shares of Epizyme, Inc. (NASDAQ:EPZM) closed at $19.74. Epizyme, Inc. (NASDAQ:EPZM) announced that data from its preclinical pipeline will be presented during the American Association for Cancer Research (AACR) Annual Meeting, to be held April 18-25 in Philadelphia, Pa.

Yandex N.V. (NASDAQ:YNDX) in last trading activity fell -0.03% to close at $17.83. Company weekly performance is 3.81% while its quarterly performance stands at -2.22%. Yandex N.V. (NASDAQ:YNDX) is -50.32% away from its 52 week high. Vetr upgraded shares of Yandex NV (NASDAQ:YNDX) from a hold rating to a buy rating in a report issued on Monday. They currently have $24.35 target price on the stock.

On Monday shares of Citigroup Inc. (NYSE:C) closed at $52.66. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 23.25%. Citigroup Inc. (NYSE:C) said that, its Chief Executive Officer Michael Corbat named Stephen Bird to run the global consumer bank, choosing a 17-year veteran with international experience to run a business with $36 billion in annual revenue.

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) in last trading activity moved down -0.72% to close at $38.51. Company weekly performance is 1.99% while its quarterly performance stands at 26.97%.
Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) is -11.74% away from its 52 week high. On 8 April, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) announced positive topline results from the second part of the Phase 3 ANNEXA-A study, which evaluated the safety and efficacy of and exanet alfa, an investigational antidote, with the Factor Xa inhibitor Eliquis (apixaban) in healthy volunteers.

On Monday shares of Frontline Ltd. (NYSE:FRO) closed at $2.83. Company’s sales growth for last 5 years was -13.20% and EPS growth for next 5 years is recorded as 5.00%. Frontline Ltd. (NYSE:FRO) said that, its $225m convertible bond hurdle will be cleared and the landmark may be followed by a much-hyped merger with sibling Frontline 2012.

Leave a Reply

Your email address will not be published. Required fields are marked *

*